[HTML][HTML] Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic …
A Arya, LPK Foko, S Chaudhry, A Sharma… - International Journal for …, 2021 - Elsevier
Artemisinin-based combination therapies (ACT) are currently used as a first-line malaria
therapy in endemic countries worldwide. This systematic review aims at presenting the …
therapy in endemic countries worldwide. This systematic review aims at presenting the …
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis
FO Maiga, M Wele, SM Toure, M Keita, CO Tangara… - Malaria Journal, 2021 - Springer
Background Artemisinin-based combination therapy (ACT) was deployed in 2005 as an
alternative to chloroquine and is considered the most efficacious treatment currently …
alternative to chloroquine and is considered the most efficacious treatment currently …
[HTML][HTML] New insights into the spread of resistance to artemisinin and its analogues
Plasmodium falciparum, the causative agent of malaria, has been developing resistance to
several drugs worldwide for more than five decades. Initially, resistance was against drugs …
several drugs worldwide for more than five decades. Initially, resistance was against drugs …
Access to Artemisinin–Triazole Antimalarials via Organo-Click Reaction: High In Vitro/In Vivo Activity against Multi-Drug-Resistant Malaria Parasites
L Herrmann, M Leidenberger, HC Quadros, BW Grau… - JACS Au, 2024 - ACS Publications
Malaria is one of the most widespread diseases worldwide. Besides a growing number of
people potentially threatened by malaria, the consistent emergence of resistance against …
people potentially threatened by malaria, the consistent emergence of resistance against …
Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic …
MS Issa, M Warsame, MHT Mahamat, IDM Saleh… - Malaria Journal, 2023 - Springer
Abstract Background Artesunate–amodiaquine (AS–AQ) and artemether–lumefantrine (AL)
are the currently recommended first-and second-line therapies for uncomplicated …
are the currently recommended first-and second-line therapies for uncomplicated …
Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular …
VS Koko, M Warsame, B Vonhm, MK Jeuronlon… - Malaria Journal, 2022 - Springer
Background Artesunate–amodiaquine (ASAQ) and Artemether–lumefantrine (AL) are the
recommended treatment for uncomplicated Plasmodium falciparum malaria in Liberia …
recommended treatment for uncomplicated Plasmodium falciparum malaria in Liberia …
Barriers to accessing malaria treatment amongst school-age children in rural Malawi
Background Over the last two decades, many countries have moved from malaria control
toward malaria elimination. However, some sub-Saharan African countries, like Malawi …
toward malaria elimination. However, some sub-Saharan African countries, like Malawi …
Two decades of molecular surveillance in Senegal reveal rapid changes in known drug resistance mutations over time
Abstract Background Drug resistance in Plasmodium falciparum is a major threat to malaria
control efforts. Pathogen genomic surveillance could be invaluable for monitoring current …
control efforts. Pathogen genomic surveillance could be invaluable for monitoring current …
Efficacy and safety of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan …
Background The emergence of artemisinin resistance in Southeast Asia and Plasmodium
falciparum kelch13 propeller gene mutations in sub-Saharan African pose the greatest …
falciparum kelch13 propeller gene mutations in sub-Saharan African pose the greatest …
Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and …
Background The burden of malaria persists in sub-Saharan Africa and the emergence of
artemisinin resistance has introduced complexity to control efforts. Monitoring the efficacy of …
artemisinin resistance has introduced complexity to control efforts. Monitoring the efficacy of …